SNCA and Parkinson disease: Studies indicated that the combined determination of oligomeric a-synuclein/total a-synuclein and β-Glucocerebrosidase activity could improve the accuracy of PD diagnosis and further highlight the need for multiple different biomarkers in order to succeed in the early detection of PD patients [99].